HOTEL NEWS

Agora Launches Conversational AI Engine for Seamless Voice AI Experiences

The new solution allows developers to use any AI model to create voice agents optimized for ultra-low latency and natural conversation flow

SECuRE trial update: 92% of pre-chemo participants experience greater than 35% drop in PSA levels across all cohorts. Cohort Expansion Phase commences.

HIGHLIGHTS Safety Review Committee (SRC) meeting confirms end of the Dose Escalation Phase and commencement of the Cohort Expansion Phase (Phase II stage) of the SECuRE study.

Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

PALMA DE MALLORCA,Spain,March 5,2025-- LaminarPharma,a leader in the development of innovative cancer therapy based on membrane lipid therapy,announced today optimistic results from its ongoing clini

Branch Unveils New Capabilities To Maximize Campaign ROI in a Privacy-First Era

The Only Mobile Measurement Partner (MMP) To Offer Advanced Data Protection Meeting HIPPA Requirements

China Unicom open the new 5G-A era

CARsgen's Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA

SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors